NDTV Profit’s special research section collates quality and in-depth equity and economy research reports from across India’s top brokerages, asset managers and research agencies. These reports offer NDTV Profit’s subscribers an opportunity to expand their understanding of companies, sectors and the economy.
Deven Choksey Research Report
The Inventurus Knowledge Solutions Ltd. will launch its initial public offering on December 12 and the offer closes for subscription on Dec. 16. The window will be open between Dec. 12 and Dec. 16. The company has fixed price band in the range of Rs 1,265 to Rs 1,329 per share.
The Rs 2,497.92-crore issue is an entirely offer-for-sale of 1.88 crore shares.
The share allotment of the issue is expected to be finalised on Dec. 17.
Outlook and Valuation:
IKS Health leverages its market leadership in healthcare operations and analytics, primarily in the U.S. With a focus on revenue cycle management, telehealth, and clinical data optimization, IKS employs proprietary technology to deliver scalable, cost-efficient, and high-impact solutions.
The company demonstrates strong client retention, with over 98.0% of revenue derived from repeat customers, underpinned by its "land and expand" strategy. The U.S. healthcare market's growth trajectory, combined with increasing reliance on outsourced services, offers significant expansion potential for IKS. At the upper end of its IPO price band of Rs 1,329, the company is valued at 61.6 times P/E, the valuation looks attractive given the growth history, and prospects, supported by high margin operations, robust technological differentiation, and an asset-light business model.
The company’s strong fundamentals, scalable solutions, and alignment with evolving healthcare needs position it as a growth-focused and sustainable investment. Hence, we assign a ‘Subscribe’ rating.
Click on the attachment to read the full report:
DISCLAIMER
This report is authored by an external party. NDTV Profit does not vouch for the accuracy of its contents nor is responsible for them in any way. The contents of this section do not constitute investment advice. For that you must always consult an expert based on your individual needs. The views expressed in the report are that of the author entity and do not represent the views of NDTV Profit.
Users have no license to copy, modify, or distribute the content without permission of the Original Owner.
RECOMMENDED FOR YOU

'Buy' Aditya Vision Shares Maintains Systematix On Multiple Positive Triggers; Hikes Target Price


Motilal Oswal Maintains 'Neutral' Stance On Piramal Finance, Revises Target Price — Here's Why

.jpg?rect=0%2C0%2C3500%2C1969&w=320)
Stay 'Neutral' On RR Kabel Shares Maintains Motilal Oswal — Check Target Price


BSE To Introduce Pre-Open Session For Index, Stock Futures From Dec 8
